Effect of Lipikar Baume AP+M on Quality of Life and Pain of Adults With Dryness or Severe Xerosis

NCT ID: NCT05765461

Last Updated: 2024-07-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

4631 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-12-31

Study Completion Date

2022-11-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims at evaluating the effect of a topical product on the improvement of quality of life and pain of patients suffering from atopic dermatitis or other skin diseases with dryness or severe xerosis. Patients aged 16 years and over are asked to apply the product once or twice a day for 2 months. They may be prescribed a corticosteroid upon decision of the dermatologist.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The general approach of the statistical methodology is the following:

* The qualitative variables are described with number and percent of each level.
* The quantitative variables are described with mean and standard deviation.
* All statistical hypotheses are performed at the 5% significance level using 2-sided tests.
* Given the large sample size, no normality assessment will be done.
* Mean reduction rate for quantitative variables is calculated as (mean v0 - mean v1)/mean v0)\*100.
* Due to the high number of zeros at inclusion in the self-assessment quantitative criteria, analyses will concern only patient with an intensity above 0 at inclusion or at final visit.
* Response rate for qualitative variables is calculated as the percent of patients with at least on level decrease between the two visits.
* Response rate for satisfaction is the percent of patients declaring being Satisfied or Very satisfied.
* Response rate for tolerance is the percent of patients declaring the tolerance High or Excellent.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis Skin Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• atopic dermatitis or other skin disease with dryness or severe xerosis

Exclusion Criteria

• patients not suffering from atopic dermatitis or other skin disease with dryness or severe xerosis
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cosmetique Active International

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Delphine Kerob

Role: STUDY_DIRECTOR

Cosmetique Active International

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dermatology practices

Zagreb, , Croatia

Site Status

Dermatology practices

Berlin, , Germany

Site Status

Dermatology practices

Lisbon, , Portugal

Site Status

Dermatology practices

Pretoria, , South Africa

Site Status

Dermatology practices

Taipei, , Taiwan

Site Status

Dermatology practices

Bangkok, , Thailand

Site Status

Dermatology practices

Hanoi, , Vietnam

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Croatia Germany Portugal South Africa Taiwan Thailand Vietnam

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LRP20001-LIPIKAR BAUME AP+M

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Xerosis and Use of Topical Moisturizer
NCT04341623 ACTIVE_NOT_RECRUITING NA